Consolidated Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7580402

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Consolidated statement of income
Statement of income
Net sales
15,408,000 JPY
2,504,000 JPY
Cost of sales
3,317,000 JPY
1,145,000 JPY
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
52,300,000 JPY
51,550,000 JPY
Depreciation
15,000 JPY
22,000 JPY
Operating expenses
Selling, general and administrative expenses
1,488,124,000 JPY
1,734,161,000 JPY
Operating expenses
Ordinary expenses
Interest expenses
Interest expenses on bonds
362,000 JPY
JPY
Gross profit (loss)
12,091,000 JPY
1,358,000 JPY
Operating profit (loss)
-1,476,033,000 JPY
-1,732,802,000 JPY
Operating expenses
Research and development expenses
1,135,847,000 JPY
1,408,443,000 JPY
General and administrative expenses
Salaries
Ordinary profit (loss)
-1,481,945,000 JPY
-1,738,636,000 JPY
Net sales
Cost of sales
Selling, general and administrative expenses
Non-operating income
Interest income
27,000 JPY
35,000 JPY
Other
89,000 JPY
98,000 JPY
Non-operating income
117,000 JPY
3,265,000 JPY
Extraordinary income
5,912,000 JPY
31,051,000 JPY
Non-operating expenses
Non-operating expenses
6,029,000 JPY
9,099,000 JPY
Share issuance costs
2,197,000 JPY
9,099,000 JPY
Extraordinary losses
5,738,000 JPY
9,629,000 JPY
Impairment losses
5,701,000 JPY
9,629,000 JPY
Other
37,000 JPY
0 JPY
Gross profit
Profit (loss) before income taxes
-1,481,772,000 JPY
-1,717,214,000 JPY
Income taxes - current
2,420,000 JPY
2,420,000 JPY
Extraordinary income
Gain on sale of non-current assets
13,000 JPY
JPY
Extraordinary losses
Income taxes
2,420,000 JPY
2,420,000 JPY
Profit (loss)
-1,484,192,000 JPY
-1,484,192,000 JPY
-1,484,192,000 JPY
-1,484,192,000 JPY
-1,719,634,000 JPY
-1,719,634,000 JPY
-1,719,634,000 JPY
-1,719,634,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.